Pharmaceuticals

Japan Women Health Diagnostics Market Size, Share, Growth, Research and Forecast 2019-2025

April 15, 2020 by OMRGlobal
Japan women health diagnostics market is growing at a CAGR of approximately 9.0% during the forecast period. According to the Ministry of Health, Labor and Welfare of Japan, cancer is an urgent public health challenge in Japan, especially for women. Over 340 thousand new cases are reported every year with female breast cancer being among the most common with 65 thousand new incidences. Since the rate of breast cancer cases has been increasing and with that a growing rate of mortality associated with the disease, there is a need for early detection and treatment. Both the younger and older generations of women in Japan are faced directly with this disease. Thus, the Japan women health diagnostic market is expected to increase.

A full report of Japan Women Health Diagnostics Market is available at:  https://www.omrglobal.com/industry-reports/japan-women-health-diagnostics-market

In the US and Europe, the most common age of diagnosis is for women around 60 years, though in Japan and in other Asian countries, there is a higher incidence of women being diagnosed in their 40’s. Rising women cancer cases and incidence in Japan increases the diagnosis of such kind of cancer to cure the same before it took the life of the patient. To overcome such issues, the Japanese government took a bold step forward in the field of global health by creating a public-private partnership called the Global Health Innovative Technology (GHIT) Fund to fund R&D for neglected tropical diseases (NTDs), diseases are not addressed by typical market mechanisms leaving nearly half of the world’s population with or at risk of a life-impacting health condition. The GHIT Fund’s current focus areas include visceral leishmaniasis, malaria, TB and Chagas disease and many other diseases, which directly contribute to the Japan women health diagnostics market.

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/japan-women-health-diagnostics-market

The overall population of Japan in the year 2017 was around 124 million and the population of females was 4 million more than males. The total population of women is more than men in Japan, this increases the rising health care services for women. This directly augments the Japan women health diagnostics market in the forecast period.

Japan Women Health Diagnostics Market- Segmentation

by Applications
  • Breast Cancer Testing
  • Cervical Cancer Testing
  • Pregnancy & Fertility Testing
  • Ovarian Cancer Testing
  • Infectious Disease Testing
  • Ultrasound Tests
  • Sexually Transmitted Disease Testing
  • Others (Osteoporosis Testing and Prenatal Genetic Testing)
by End-User
  • Diagnostic and Imaging Centers
  • Hospitals and Clinics
  • Home Care
Visit for Global Women Health Diagnostics Market Report at:  https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size

Company Profiles
  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • Biomerieux SA
  • F. Hoffmann-La Roche Ltd.
  • GenMark Diagnostics, Inc.
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Nova Biomedical Pte. Ltd.
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research


Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404

0 Comments

0 Comments

Post a Comment